Rhythm Pharmaceuticals
RYTM
RYTM
87 hedge funds and large institutions have $846M invested in Rhythm Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 4 closing their positions.
Holders
87
Holders Change
+13
Holders Change %
+17.57%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
17
Increased
29
Reduced
25
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TG
1
TRV GP
Boston,
Massachusetts
|
$54.3M |
| 2 |
O
2
OrbiMed
New York
|
$21.6M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$43.6M |
| 4 |
RCM
4
RA Capital Management
Boston,
Massachusetts
|
$51.7M |
| 5 |
5
Citigroup
New York
|
$91K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWNA
76
Marshall Wace North America
New York
| $33K | +$33K | +1,195 | New |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| $30K | +$23.5K | +859 | +364% |
|
|
AIP
78
Ameritas Investment Partners
Lincoln,
Nebraska
| $28K | – | – | – |
|
|
KPW
79
Kore Private Wealth
New York
| $14K | – | – | – |
|
80
Twin Tree Management
Dallas,
Texas
| $8K | +$8K | +283 | New |
|
81
Rockefeller Capital Management
New York
| $7K | +$7K | +249 | New |
|
82
Daiwa Securities Group
Tokyo,
Japan
| $6K | -$2.22K | -81 | -27% |
|
83
UBS Group
Zurich,
Switzerland
| $5K | -$274K | -10,178 | -98% |
|
|
AG
84
Advisor Group
Phoenix,
Arizona
| $5K | +$5K | +200 | New |
|
85
US Bancorp
Minneapolis,
Minnesota
| $3K | +$3K | +99 | New |
|
86
Citadel Advisors
Miami,
Florida
| – | -$391K | -14,521 | Closed |
|
|
BFM
87
Boothbay Fund Management
New York
| – | -$296K | -11,000 | Closed |
|
88
D.E. Shaw & Co
New York
| – | -$295K | -10,982 | Closed |
|
|
MAM
89
Meeder Asset Management
Dublin,
Ohio
| – | -$16K | -583 | Closed |
|